ADG-152

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameADG-152
Drug Alias NameADG152
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > T cell engagers
Mechanisms of ActionAnti-CD20Anti-CD3
TargetsB-lymphocyte antigen CD20T cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAdagene (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdagene (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A